| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Superoxide Dismutase | 23 | 2013 | 223 | 1.990 |
Why?
|
| Amyotrophic Lateral Sclerosis | 23 | 2019 | 517 | 1.610 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 5 | 2026 | 45 | 1.460 |
Why?
|
| Paralysis, Hyperkalemic Periodic | 6 | 2020 | 8 | 1.170 |
Why?
|
| Mutation | 23 | 2019 | 2670 | 1.050 |
Why?
|
| Muscle, Skeletal | 11 | 2022 | 788 | 0.920 |
Why?
|
| Sodium Channels | 7 | 2012 | 26 | 0.820 |
Why?
|
| Catatonia | 1 | 2023 | 5 | 0.810 |
Why?
|
| Leukoencephalopathies | 1 | 2023 | 25 | 0.790 |
Why?
|
| RNA-Binding Protein FUS | 5 | 2019 | 53 | 0.730 |
Why?
|
| Motor Neuron Disease | 5 | 2008 | 28 | 0.680 |
Why?
|
| Myotonia | 3 | 2008 | 3 | 0.530 |
Why?
|
| Superoxide Dismutase-1 | 14 | 2016 | 148 | 0.450 |
Why?
|
| Muscle Contraction | 3 | 2020 | 209 | 0.440 |
Why?
|
| Muscle Fatigue | 1 | 2012 | 49 | 0.360 |
Why?
|
| Potassium | 4 | 2020 | 98 | 0.360 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2011 | 23 | 0.340 |
Why?
|
| Paralyses, Familial Periodic | 4 | 1999 | 4 | 0.340 |
Why?
|
| Metals | 4 | 2009 | 65 | 0.330 |
Why?
|
| Motor Neurons | 7 | 2019 | 219 | 0.330 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2009 | 281 | 0.320 |
Why?
|
| Axonal Transport | 4 | 2013 | 32 | 0.300 |
Why?
|
| Mutation, Missense | 4 | 2015 | 190 | 0.300 |
Why?
|
| Animals | 32 | 2023 | 21450 | 0.290 |
Why?
|
| Copper | 3 | 2007 | 58 | 0.270 |
Why?
|
| Pyridines | 2 | 2026 | 120 | 0.270 |
Why?
|
| Zinc | 3 | 2005 | 95 | 0.270 |
Why?
|
| Point Mutation | 5 | 2005 | 168 | 0.260 |
Why?
|
| Disulfides | 2 | 2009 | 67 | 0.260 |
Why?
|
| Humans | 43 | 2026 | 65635 | 0.260 |
Why?
|
| Mice | 19 | 2023 | 11172 | 0.250 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2020 | 98 | 0.250 |
Why?
|
| Amino Acid Substitution | 7 | 2008 | 238 | 0.240 |
Why?
|
| Homeodomain Proteins | 3 | 2022 | 277 | 0.240 |
Why?
|
| NAV1.4 Voltage-Gated Sodium Channel | 2 | 2015 | 2 | 0.220 |
Why?
|
| Sodium | 3 | 2015 | 60 | 0.220 |
Why?
|
| Cytoplasm | 4 | 2014 | 283 | 0.210 |
Why?
|
| RNA, Messenger | 5 | 2018 | 1580 | 0.200 |
Why?
|
| Canavan Disease | 1 | 2023 | 11 | 0.190 |
Why?
|
| Inclusion Bodies | 2 | 2016 | 17 | 0.190 |
Why?
|
| Heart | 2 | 2023 | 298 | 0.190 |
Why?
|
| Heart Rate | 1 | 2023 | 334 | 0.180 |
Why?
|
| Myoblasts | 1 | 2022 | 66 | 0.170 |
Why?
|
| Cell Line | 6 | 2022 | 2029 | 0.160 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 160 | 0.160 |
Why?
|
| Neurons | 3 | 2018 | 935 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2002 | 251 | 0.150 |
Why?
|
| Mice, Transgenic | 7 | 2016 | 1291 | 0.150 |
Why?
|
| Golgi Apparatus | 1 | 2019 | 65 | 0.150 |
Why?
|
| Spinal Cord | 5 | 2016 | 210 | 0.150 |
Why?
|
| Dyneins | 3 | 2008 | 112 | 0.140 |
Why?
|
| Mutant Proteins | 2 | 2009 | 105 | 0.140 |
Why?
|
| Calcium | 2 | 2020 | 584 | 0.140 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 177 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 1233 | 0.140 |
Why?
|
| Protein Structure, Secondary | 6 | 2008 | 260 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2022 | 2189 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 39 | 0.130 |
Why?
|
| Bevacizumab | 1 | 2017 | 61 | 0.130 |
Why?
|
| Recombinant Proteins | 5 | 2008 | 708 | 0.130 |
Why?
|
| Huntington Disease | 1 | 2018 | 164 | 0.120 |
Why?
|
| Kinetics | 5 | 2008 | 757 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 333 | 0.120 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 102 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2011 | 321 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2017 | 209 | 0.120 |
Why?
|
| Muscles | 2 | 1988 | 179 | 0.120 |
Why?
|
| Binding Sites | 5 | 2009 | 917 | 0.120 |
Why?
|
| Diaphragm | 1 | 2015 | 25 | 0.120 |
Why?
|
| Actins | 2 | 1988 | 264 | 0.120 |
Why?
|
| Middle Aged | 4 | 2026 | 18434 | 0.110 |
Why?
|
| Mass Spectrometry | 4 | 2013 | 296 | 0.110 |
Why?
|
| Computational Biology | 1 | 2017 | 368 | 0.110 |
Why?
|
| Cyclopropanes | 2 | 2026 | 56 | 0.110 |
Why?
|
| Models, Molecular | 6 | 2009 | 1155 | 0.110 |
Why?
|
| Oxidation-Reduction | 2 | 2008 | 328 | 0.110 |
Why?
|
| Protein Conformation | 5 | 2009 | 790 | 0.110 |
Why?
|
| Cysteine | 2 | 2007 | 108 | 0.110 |
Why?
|
| Dithiothreitol | 2 | 2005 | 18 | 0.100 |
Why?
|
| Electrophysiology | 3 | 2008 | 89 | 0.100 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2014 | 35 | 0.100 |
Why?
|
| Genetic Variation | 2 | 2009 | 395 | 0.100 |
Why?
|
| DNA Helicases | 2 | 2016 | 201 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 466 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2026 | 745 | 0.100 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 35 | 0.100 |
Why?
|
| Patents as Topic | 1 | 2012 | 6 | 0.100 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 68 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 149 | 0.090 |
Why?
|
| Potassium Channels | 1 | 2012 | 55 | 0.090 |
Why?
|
| Male | 5 | 2026 | 31285 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2014 | 351 | 0.090 |
Why?
|
| Transfection | 5 | 2008 | 700 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 718 | 0.090 |
Why?
|
| Monensin | 1 | 2011 | 4 | 0.090 |
Why?
|
| Capsaicin | 1 | 2011 | 19 | 0.090 |
Why?
|
| Albuterol | 1 | 2011 | 24 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2009 | 116 | 0.080 |
Why?
|
| Cell Lineage | 2 | 2023 | 282 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2011 | 139 | 0.080 |
Why?
|
| Cell Nucleus | 4 | 2018 | 634 | 0.080 |
Why?
|
| Disease Models, Animal | 5 | 2022 | 2319 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2010 | 322 | 0.080 |
Why?
|
| Phenotype | 3 | 2008 | 1235 | 0.080 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 2009 | 2 | 0.080 |
Why?
|
| Holoenzymes | 1 | 2009 | 3 | 0.080 |
Why?
|
| Titrimetry | 1 | 2009 | 11 | 0.080 |
Why?
|
| Electrophoresis | 1 | 2009 | 16 | 0.080 |
Why?
|
| Adult | 6 | 2026 | 17508 | 0.070 |
Why?
|
| Crystallography, X-Ray | 6 | 2008 | 413 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 372 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 1172 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1573 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 465 | 0.070 |
Why?
|
| Detergents | 1 | 2008 | 35 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 1633 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2009 | 152 | 0.060 |
Why?
|
| Female | 7 | 2026 | 34298 | 0.060 |
Why?
|
| Action Potentials | 2 | 2015 | 113 | 0.060 |
Why?
|
| Zebrafish | 1 | 2010 | 374 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 87 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 451 | 0.060 |
Why?
|
| Enzyme Stability | 2 | 2007 | 47 | 0.060 |
Why?
|
| Protein Folding | 1 | 2008 | 268 | 0.060 |
Why?
|
| Polymorphism, Genetic | 2 | 1997 | 199 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 573 | 0.060 |
Why?
|
| Calorimetry, Differential Scanning | 2 | 2005 | 32 | 0.060 |
Why?
|
| Membrane Potentials | 2 | 2015 | 140 | 0.060 |
Why?
|
| Genes | 1 | 1986 | 90 | 0.060 |
Why?
|
| Muscle Strength | 1 | 2026 | 41 | 0.060 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 385 | 0.060 |
Why?
|
| Histidine | 1 | 2005 | 36 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 1 | 2005 | 102 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 100 | 0.050 |
Why?
|
| Arginine | 1 | 2005 | 136 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2026 | 5818 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 181 | 0.050 |
Why?
|
| Disease Progression | 1 | 2008 | 1225 | 0.050 |
Why?
|
| RNA Helicases | 2 | 2016 | 99 | 0.050 |
Why?
|
| Molecular Weight | 3 | 2008 | 194 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2003 | 17 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2023 | 34 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2023 | 40 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2023 | 39 | 0.050 |
Why?
|
| Iodoacetamide | 1 | 2002 | 2 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2003 | 83 | 0.050 |
Why?
|
| Rats | 2 | 1997 | 1996 | 0.050 |
Why?
|
| Proteomics | 2 | 2019 | 299 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2002 | 200 | 0.050 |
Why?
|
| PAX3 Transcription Factor | 1 | 2022 | 12 | 0.050 |
Why?
|
| Insecta | 1 | 2002 | 36 | 0.040 |
Why?
|
| Aging | 1 | 2008 | 775 | 0.040 |
Why?
|
| Protein Denaturation | 1 | 2002 | 67 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2022 | 30 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 222 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2002 | 85 | 0.040 |
Why?
|
| DNA Primers | 1 | 2002 | 301 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2002 | 196 | 0.040 |
Why?
|
| Muscle Development | 1 | 2022 | 62 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 91 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 200 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1389 | 0.040 |
Why?
|
| Regeneration | 1 | 2022 | 126 | 0.040 |
Why?
|
| Temperature | 2 | 2004 | 317 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2022 | 292 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 408 | 0.040 |
Why?
|
| Coat Protein Complex I | 1 | 2019 | 5 | 0.040 |
Why?
|
| Arsenites | 1 | 2019 | 8 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 2019 | 52 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 1998 | 4 | 0.040 |
Why?
|
| Cytochrome b Group | 1 | 1998 | 20 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 514 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2009 | 3162 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 36 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 161 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 1998 | 89 | 0.030 |
Why?
|
| Protein Binding | 3 | 2009 | 1633 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 1226 | 0.030 |
Why?
|
| Models, Biological | 2 | 2009 | 1193 | 0.030 |
Why?
|
| Epirubicin | 1 | 2017 | 3 | 0.030 |
Why?
|
| Isoleucine | 1 | 1997 | 9 | 0.030 |
Why?
|
| Valine | 1 | 1997 | 32 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 71 | 0.030 |
Why?
|
| Hyperkalemia | 1 | 1997 | 20 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 84 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2017 | 68 | 0.030 |
Why?
|
| Remission Induction | 1 | 2017 | 149 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1988 | 100 | 0.030 |
Why?
|
| Nurse Specialists | 1 | 2017 | 1 | 0.030 |
Why?
|
| Malawi | 1 | 2017 | 9 | 0.030 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2017 | 7 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 17 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2018 | 541 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2018 | 154 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2017 | 20 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 1997 | 44 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2013 | 963 | 0.030 |
Why?
|
| Oncology Nursing | 1 | 2017 | 16 | 0.030 |
Why?
|
| Health Planning | 1 | 2017 | 32 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1997 | 94 | 0.030 |
Why?
|
| RNA Recognition Motif Proteins | 1 | 2016 | 5 | 0.030 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2016 | 9 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2026 | 2252 | 0.030 |
Why?
|
| Plasmids | 2 | 2008 | 294 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1996 | 40 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 1996 | 133 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1997 | 162 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2008 | 169 | 0.030 |
Why?
|
| Nurse's Role | 1 | 2017 | 131 | 0.030 |
Why?
|
| COS Cells | 2 | 2007 | 180 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2017 | 202 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 436 | 0.030 |
Why?
|
| Horse Diseases | 1 | 1995 | 20 | 0.030 |
Why?
|
| Education, Medical | 1 | 2017 | 183 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2017 | 337 | 0.030 |
Why?
|
| Horses | 2 | 2008 | 53 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 2004 | 162 | 0.020 |
Why?
|
| Decapodiformes | 1 | 2013 | 13 | 0.020 |
Why?
|
| Dimerization | 2 | 2004 | 145 | 0.020 |
Why?
|
| Myosins | 1 | 2014 | 118 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2013 | 80 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2014 | 306 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 672 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 208 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 987 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2013 | 173 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 1588 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1979 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 897 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 497 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 364 | 0.020 |
Why?
|
| Adolescent | 1 | 2022 | 6349 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 617 | 0.020 |
Why?
|
| Base Sequence | 2 | 1998 | 1331 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 689 | 0.020 |
Why?
|
| Aged | 1 | 2026 | 15087 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 503 | 0.020 |
Why?
|
| Thyroglobulin | 1 | 2008 | 9 | 0.020 |
Why?
|
| Static Electricity | 1 | 2009 | 170 | 0.020 |
Why?
|
| Solvents | 1 | 2008 | 60 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2008 | 45 | 0.020 |
Why?
|
| Dynactin Complex | 1 | 2008 | 7 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 1988 | 20 | 0.020 |
Why?
|
| Cell Fusion | 1 | 1988 | 39 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 1988 | 34 | 0.020 |
Why?
|
| tau Proteins | 1 | 2009 | 212 | 0.020 |
Why?
|
| Chromatin | 1 | 2013 | 643 | 0.020 |
Why?
|
| Chickens | 1 | 1988 | 94 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 320 | 0.020 |
Why?
|
| Dipeptides | 1 | 1988 | 69 | 0.020 |
Why?
|
| Synapses | 1 | 2009 | 195 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 257 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 119 | 0.020 |
Why?
|
| Solubility | 1 | 2008 | 193 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 322 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2007 | 37 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2007 | 52 | 0.020 |
Why?
|
| Cell Division | 1 | 1988 | 450 | 0.020 |
Why?
|
| Serine | 1 | 2007 | 90 | 0.020 |
Why?
|
| Axons | 1 | 2007 | 124 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1986 | 46 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 34 | 0.010 |
Why?
|
| Transition Temperature | 1 | 2005 | 6 | 0.010 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2005 | 19 | 0.010 |
Why?
|
| Smad2 Protein | 1 | 2004 | 8 | 0.010 |
Why?
|
| Smad3 Protein | 1 | 2004 | 17 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 2004 | 114 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 2004 | 72 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2004 | 149 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2004 | 134 | 0.010 |
Why?
|
| Algorithms | 1 | 2008 | 1051 | 0.010 |
Why?
|
| Amyloid | 1 | 2003 | 74 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2003 | 137 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 391 | 0.010 |
Why?
|
| Water | 1 | 2003 | 317 | 0.010 |
Why?
|
| Polymers | 1 | 2004 | 332 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2004 | 526 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1986 | 929 | 0.010 |
Why?
|
| Coenzymes | 1 | 1998 | 7 | 0.010 |
Why?
|
| Electron Transport Complex III | 1 | 1998 | 5 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 1998 | 25 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 1998 | 24 | 0.010 |
Why?
|
| Ubiquinone | 1 | 1998 | 22 | 0.010 |
Why?
|
| Folic Acid | 1 | 1998 | 42 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 173 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 363 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 300 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 104 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1998 | 278 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 3500 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1996 | 16 | 0.010 |
Why?
|
| Family Health | 1 | 1996 | 68 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 1998 | 351 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1996 | 417 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1995 | 267 | 0.010 |
Why?
|
| Exercise | 1 | 1998 | 970 | 0.010 |
Why?
|
| Child | 1 | 1997 | 4633 | 0.000 |
Why?
|
| Time Factors | 1 | 1995 | 3777 | 0.000 |
Why?
|